ctSearch Results
Original Query
What is cancer pomalidomide?
Search Results
- cancer pomalidomide
Preview- Apparently, ruben Niesvizky, the studys principal sum investigator, associate professor of medicine at Kurt weill Cornell Medical College, and director (i.e., staff) of the Multiple Myeloma Service at the Center of Excellence for Lymphoma and Myeloma at New York-Presbyterian Hospital/Weill Cornell Medical Center. Lymphoma, cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma (i.e., hodgkin disease), which is marked by the presence of a type of cell called the Reed-Sternberg cell (i.e., reed cell, or sternberg cell) (i.e., reed-sternberg cell). The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer. Medicine, refers to the practices and procedures used for the prevention, treatment, or relief of symptoms of a diseases or abnormal conditions. This term may also refer to a legal drug used for the same purpose. Investigator is a researcher in a clinical trial or clinical study. Clinical, having to do with the examination and treatment of patients.
- It really is clear that, pomalidomide, developed by Celgene Corportation, is an immuno-modulatory agent that stimulates the patients own immune system to fight off cancer cells. Immune system is the complex (i.e., sequence) group of organs and cells that defends the body against infections and other diseases.
- It might seem to be apparant that, the drug is taken in pill cast and can target (i.e., target organ) the microenvironment of the cancer cell, not just the malignant cell itself a characteristic (i.e., character) unique to pomalidomide.
Contact
Web: http://c-t-search.info/cancer-expertE-mail: ask.ctsearch@gmail.com
© 2013-2014, Cancer Expert, ctSearch - Context Search Engine.
